Case-control study on evaluation of BCG vaccination of newborn in Rangoon, Burma.
A case-control study was carried out on 311 tuberculous children under 5 years of age and 1536 non-tuberculous controls, matched for age, sex and the sector of residence, to evaluate the effectiveness of BCG vaccination of newborns in Rangoon, Burma. BCG vaccination status of both the cases and their matched controls was recorded. BCG vaccination in the newborn conferred 38% protection against the sum total of all forms of tuberculosis. The protective efficacy varied with the different forms of tuberculosis. It was only 20% for primary complex and 52% and 80% for tuberculous meningitis and disseminated tuberculosis, respectively. The protective effect of BCG vaccination was highest during the first 3 years after vaccination and then waned during the subsequent years. Although the protective efficacy seemed to be low, the impact of a BCG vaccination programme on the preventable deaths, neurological sequelae and the health services expenses is considerable.
D001500:BCG Vaccine; D002675:Child, Preschool; D006801:Humans; D007231:Infant, Newborn; D002052:Myanmar; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*; D014611:Vaccination
D001500:BCG Vaccine